Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Dignity Sciences reports data from phase II trial of DS-107E in atopic dermatitis

July 14, 2014

NDA for Kythera Biopharmaceuticals' ATX-101 accepted

July 11, 2014

Japanese approval for Dovobet to treat psoriasis vulgaris

July 8, 2014

Dermira licenses Cimzia for psoriasis

July 7, 2014

FDA grants orphan drug designation to trifarotene for congenital ichthyosis

July 4, 2014

Merz signs agreement with Brickell Biotech for novel retinoid therapy

July 3, 2014

Aclaris Therapeutics reports data from phase II trial of A-101 in seborrheic keratosis

July 2, 2014

Kyowa Hakko Kirin patent reports new CCR10 receptor antagonists

June 25, 2014

XenoPort begins phase II trial of XP-23829 in patients with psoriasis

June 25, 2014

Merck KGaA to begin phase I trial of MSB-0010841 in patients with psoriasis

June 25, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...